Buchumschlag

Extracellular Vesicle miRNAs as Biomarkers of Asthma Severity

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chandrashekhar Prasad, Rachel Griffard, Dong Pei, Steven Haworth, Navneet K. Dhillon, Mario Castro, Isaac Kirubakaran Sundar
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Allergy
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Real‐World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma ( IRSA )
von: M. Beatrice Bilò, et al.
Veröffentlicht: (2024)

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma
von: Duong Duc Pham, et al.
Veröffentlicht: (2025)

Correspondence: “Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management”
von: Ourania S. Kotsiou, et al.
Veröffentlicht: (2025)

Reply to Correspondence: ‘Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management’
von: Nuria Contreras, et al.
Veröffentlicht: (2025)

Genetic and Environmental Contributions to Serological Biomarkers of Extracellular Matrix Remodeling in Asthma: A Twin Study
von: Matej Andelic, et al.
Veröffentlicht: (2025)

Association Between Prevalence of Anemia and Asthma Severity
von: Mi‐So Kim, et al.
Veröffentlicht: (2025)

Role for Complement C5 in Eosinophilic Inflammation of Severe Asthma
von: Cong Dong, et al.
Veröffentlicht: (2025)

An Algorithm for the Diagnosis and Management of Severe Asthma in Children and Adolescents
von: Eckard Hamelmann, et al.
Veröffentlicht: (2025)

Correspondence to “Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma”
von: C. Mümmler, et al.
Veröffentlicht: (2025)

Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry
von: Stéphanie Wanin, et al.
Veröffentlicht: (2025)

Dupilumab Effectiveness in Biologic‐Naïve and Switched Severe Asthma in Real Life
von: Catherine Moermans, et al.
Veröffentlicht: (2025)

Multiomic Integration Analysis for Monitoring Severe Asthma Treated With Mepolizumab or Omalizumab
von: Nuria Contreras, et al.
Veröffentlicht: (2024)

Retrospective Analysis of Self‐Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
von: Hazal Kayıkçı, et al.
Veröffentlicht: (2025)

Oncostatin‐M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma
von: Stephane Esnault, et al.
Veröffentlicht: (2024)

Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma
von: Jessica Gates, et al.
Veröffentlicht: (2025)

Moesin, a Cytoskeletal‐Associated Protein, Outperforms Candidate Biomarkers in Identifying Asthma Exacerbation
von: Pureun‐Haneul Lee, et al.
Veröffentlicht: (2026)

Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma
von: Keita Hirai, et al.
Veröffentlicht: (2025)

Disruption of the Vagal TRPA1‐Pulmonary Neuroendocrine Cell Axis Reduces Asthma Severity
von: Xintong Feng, et al.
Veröffentlicht: (2025)

Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort
von: Eve Denton, et al.
Veröffentlicht: (2024)

Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
von: Marianne Baastrup Soendergaard, et al.
Veröffentlicht: (2025)

Asthma in Pregnancy
von: Eve Denton, et al.
Veröffentlicht: (2025)

Early Reduction of FeNO on Anti‐ IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
von: Marianne Baastrup Soendergaard, et al.
Veröffentlicht: (2024)

High‐Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma
von: Lorenz Wirth, et al.
Veröffentlicht: (2025)

How Badly Does India Need Biologics for Severe Asthma?
von: Subhabrata Moitra, et al.
Veröffentlicht: (2025)

Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma
von: Robert Greig, et al.
Veröffentlicht: (2025)

Associations Between Blood Eosinophil Surface Proteins and Clinical Traits in Severe Asthma and Chronic Rhinosinusitis With Nasal Polyposis
von: Emeline Delaunay, et al.
Veröffentlicht: (2025)

Circulating Piwi‐Interacting RNAs Associate With Childhood Asthma ICS Response With Vitamin D Effect Modification
von: Jiang Li, et al.
Veröffentlicht: (2026)

Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto's Thyroiditis Are Risk Factors for Early‐Onset, Severe and Prolonged Alopecia Areata
von: Annika Friedrich, et al.
Veröffentlicht: (2025)

Basal Serum Tryptase Outperforms Hereditary Alpha Tryptasemia as a Biomarker of Food Allergy Severity
von: D. Loli‐Ausejo, et al.
Veröffentlicht: (2025)

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity
von: Lars I. Andersson, et al.
Veröffentlicht: (2026)

Reply to Correspondence “Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food‐Allergic in Children With Severe Asthma: An Observational Study”
von: Stefania Arasi, et al.
Veröffentlicht: (2025)

How FEV 1 Improvement Induced by Anti‐ IL ‐5 in Severe Type‐2 Asthma Is Linked to Mucus Plugs Clearance
von: Alain Michils, et al.
Veröffentlicht: (2024)

Sensitisation to Staphylococcus Aureus Enterotoxin; a Driver of Airway Inflammation in Severe Asthma?
von: Freja Friis Lajer, et al.
Veröffentlicht: (2025)

Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
von: Michael E. Wechsler, et al.
Veröffentlicht: (2026)

EAACI Guidelines on Environmental Science for Allergy and Asthma—Recommendations on the Impact of Indoor Air Pollutants on the Risk of New‐Onset Asthma and on Asthma‐Related Outcomes
von: Ioana Agache, et al.
Veröffentlicht: (2025)

Asthma Remission in Adults: Role of Age at Asthma Onset, Smoking, Obesity, and Allergic Rhinitis
von: Reshed Abohalaka, et al.
Veröffentlicht: (2025)

Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
von: Renaud Louis, et al.
Veröffentlicht: (2025)

Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma
von: Kirsten E. Stewart, et al.
Veröffentlicht: (2025)

Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control—A Systematic Review for the EAACI Guidelines of Environmental Science for Allergic Diseases and Asthma
von: Ioana Agache, et al.
Veröffentlicht: (2025)

Asthma Control and Risk Factors for Poor Asthma Outcomes in Chinese Asthma Patients: Baseline Analysis of a Multi‐Centre, Single‐Arm Study (CARE4ALL)
von: Kewu Huang, et al.
Veröffentlicht: (2025)